(Q37469235)

20 August 2017

1 reference

title

The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

20 August 2017

main subject

1 reference

1 reference

Evanthia Diamanti-Kandarakis

series ordinal

1

object named as

E Diamanti-Kandarakis

1 reference

20 August 2017

E Kandaraki

2

1 reference

20 August 2017

C Christakou

series ordinal

3

1 reference

20 August 2017

D Panidis

series ordinal

4

1 reference

20 August 2017

publication date

21 April 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

10

1 reference

20 August 2017

issue

4

1 reference

20 August 2017

page(s)

431-441

1 reference

Estrogen increases apolipoprotein (apo) A-I secretion in hep G2 cells by modulating transcription of the apo A-I gene promoter

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2009.00588.X

Crossref

reference URL

Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2009.00588.X

Crossref

reference URL

Risks of statin use during pregnancy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2009.00588.X

Crossref

reference URL

10.1111/J.1467-789X.2009.00588.X

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference